← Back to Search

HPV Self-Sampling for Cervical Cancer

N/A
Recruiting
Led By Carolyn Fang, PhD
Research Sponsored by Fox Chase Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Assigned female sex at birth
Be older than 18 years old
Must not have
Prior diagnosis of cervical cancer or abnormality (e.g., dysplasia)
Had a hysterectomy/removal of the cervix
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Summary

"This trial aims to see if Hispanic/Latina women are willing to collect a cervico-vaginal sample for HPV testing. They want to know if giving these women a brief educational session will make

Who is the study for?
This trial is for Hispanic/Latina women who are underscreened for cervical cancer. It aims to see if they're willing to self-collect samples for HPV testing and whether a brief educational session can make this more acceptable.
What is being tested?
The study tests the acceptability of an HPV self-sampling kit among Latinas, comparing two approaches: receiving the kit alone versus receiving it with group education by a bilingual health educator.
What are the potential side effects?
Since this trial involves non-invasive self-sampling for HPV and an educational component, there are no direct medical side effects associated with typical drug interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was assigned female at birth.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with cervical cancer or a related abnormality.
Select...
I have had my uterus and/or cervix removed.
Select...
I am currently pregnant or have been pregnant in the last three months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility
Secondary outcome measures
Participation in screening

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Education Plus Mailed KitExperimental Treatment2 Interventions
Participants receive information about cervical cancer risks and screening guidelines in a small-group format with a bilingual health educator. Participants also receive an HPV self-sampling kit in the mail with instructions on how to self-collect a sample and return it to the lab for testing.
Group II: Mailed Kit Only ControlActive Control1 Intervention
Participants receive an HPV self-sampling kit in the mail with instructions on how to self-collect a sample and return it to the lab for testing.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Group Education
2011
N/A
~3300

Find a Location

Who is running the clinical trial?

Fox Chase Cancer CenterLead Sponsor
233 Previous Clinical Trials
38,811 Total Patients Enrolled
Pennsylvania Breast Cancer CoalitionUNKNOWN
Carolyn Fang, PhDPrincipal InvestigatorFox Chase Cancer Center
2 Previous Clinical Trials
266 Total Patients Enrolled
~0 spots leftby Sep 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top